2095417-02-8
Chemical Structure
5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine
- CAS No.: 2095417-02-8
- Formula:C35H35N3O8
- Molecular Weight:625.67
IUPAC Name: 4-amino-1-((2R,3R,4R,5R)-5-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-5-(furan-2-yl)pyrimidin-2(1H)-one
InChIKey: BVCNNNKIJMNDAV-WTGZKXAYSA-N
SMILES: NC(C(C1=CC=CO1)=CN2[C@H]3[C@H](OC)[C@H](O)[C@@H](COC(C4=CC=CC=C4)(C5=CC=C(OC)C=C5)C6=CC=C(OC)C=C6)O3)=NC2=O
Biological Activity: 5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine | 5-(Furan-2-yl)-2’-O-methyl-5’-O-DMTr-cytidine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
